BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 36052864)

  • 1. Outcomes from 8 years of cervical cancer screening at a rural screen-and-treat site in northern Tanzania.
    Maillie L; Yussuph A; Chirangi B; Schroeder K
    Int J Gynaecol Obstet; 2023 Feb; 160(2):604-611. PubMed ID: 36052864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of human papillomavirus video education for women participating in mass cervical cancer screening in Tanzania.
    Cooper EC; Maher JA; Naaseh A; Crawford EW; Chinn JO; Runge AS; Lucas AN; Zezoff DC; Bera KR; Dinicu AI; White KM; Tewari SE; Hari A; Bernstein M; Chang J; Ziogas A; Pearre DC; Tewari KS
    Am J Obstet Gynecol; 2021 Jan; 224(1):105.e1-105.e9. PubMed ID: 32682861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro Region, Tanzania.
    Cunningham MS; Skrastins E; Fitzpatrick R; Jindal P; Oneko O; Yeates K; Booth CM; Carpenter J; Aronson KJ
    BMJ Open; 2015 Mar; 5(3):e005828. PubMed ID: 25757944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability and feasibility of self-sampling and follow-up attendance after text message delivery of human papillomavirus results: A cross-sectional study nested in a cohort in rural Tanzania.
    Mremi A; Linde DS; Mchome B; Mlay J; Schledermann D; Blaakaer J; Rasch V
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):802-810. PubMed ID: 33555038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanzanian women´s knowledge about Cervical Cancer and HPV and their prevalence of positive VIA cervical screening results. Data from a Prevention and Awareness Campaign in Northern Tanzania, 2017 - 2019.
    Henke A; Kluge U; Borde T; Mchome B; Serventi F; Henke O
    Glob Health Action; 2021 Jan; 14(1):1852780. PubMed ID: 33371824
    [No Abstract]   [Full Text] [Related]  

  • 6. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 7. Visual inspection with acetic acid screening for cervical cancer among women receiving anti-retroviral therapy for human immunodeficiency virus infection in northern Tanzania.
    Chinn JO; Runge AS; Dinicu AI; Chang J; Maher JA; Crawford EW; Naaseh A; Cooper EC; Zezoff DC; White KM; Lucas AN; Bera KR; Bernstein M; Hari A; Ziogas A; Tewari SE; Pearre DC; Tewari KS
    J Obstet Gynaecol Res; 2021 Dec; 47(12):4365-4370. PubMed ID: 34614540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial.
    Denny L; Kuhn L; De Souza M; Pollack AE; Dupree W; Wright TC
    JAMA; 2005 Nov; 294(17):2173-81. PubMed ID: 16264158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "The best thing is that you are doing it for yourself" - perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study.
    Bakiewicz A; Rasch V; Mwaiselage J; Linde DS
    BMC Womens Health; 2020 Mar; 20(1):65. PubMed ID: 32234028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for cervical cancer among distinct populations in low-resource countries: feasibility of cervical cancer screen-and-treat program on ukerewe island of lake victoria, Tanzania.
    Hari AY; Bernstein M; Temko J; Brabender DE; Shen A; Tewari KS
    Curr Opin Obstet Gynecol; 2022 Feb; 34(1):20-27. PubMed ID: 34967811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
    Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
    BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a human papillomavirus screen-and-treat model in Mwanza, Tanzania: training local healthcare workers for sustainable impact.
    Bernstein M; Hari A; Aggarwal S; Lee D; Farfel A; Patel P; Raman K; Raja S; Fenning R; Lieber M; Minteer W; Denny S; Ries M
    Int Health; 2018 May; 10(3):197-201. PubMed ID: 29579207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake and safety of community-based "screen-and-treat" with thermal ablation preventive therapy for cervical cancer prevention in rural Lilongwe, Malawi.
    Chinula L; Topazian HM; Mapanje C; Varela A; Chapola J; Limarzi L; Stanley C; Hosseinipour M; Gopal S; Tang JH
    Int J Cancer; 2021 Jul; 149(2):371-377. PubMed ID: 33687746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Most women diagnosed with cervical cancer by a visual screening program in Tanzania completed treatment: evidence from a retrospective cohort study.
    Gard AC; Soliman AS; Ngoma T; Mwaiselage J; Kahesa C; Chamberlain RM; Harlow SD
    BMC Public Health; 2014 Sep; 14():910. PubMed ID: 25187329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Cervical Cancer Screening Programs in Côte d'Ivoire, Guyana, and Tanzania: Effect of HIV Status.
    Anderson J; Wysong M; Estep D; Besana G; Kibwana S; Varallo J; Sun K; Lu E
    PLoS One; 2015; 10(9):e0139242. PubMed ID: 26405784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and acceptability of human papillomavirus self-sampling in a semi-urban area in northern Tanzania.
    Mahande MJ; Oneko O; Amour C; Pollie M; Smith C; Mboya IB; Finkel M
    Int J Gynaecol Obstet; 2021 Jul; 154(1):113-118. PubMed ID: 33404089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the costs of cervical cancer screening in high-burden Sub-Saharan African countries.
    Mvundura M; Tsu V
    Int J Gynaecol Obstet; 2014 Aug; 126(2):151-5. PubMed ID: 24792401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
    Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
    Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
    Korn AK; Muzingwani L; O'Bryan G; Ensminger A; Boylan AD; Kafidi EL; Kashali M; Ashipala L; Nitschke AM; Dziuban EJ; Forster N; Eckert LO; O'Malley G
    PLoS One; 2022; 17(2):e0263920. PubMed ID: 35171941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of thermocoagulation in a screen-and-treat approach for the treatment of cervical precancerous lesions in sub-Saharan Africa.
    Viviano M; Kenfack B; Catarino R; Tincho E; Temogne L; Benski AC; Tebeu PM; Meyer-Hamme U; Vassilakos P; Petignat P
    BMC Womens Health; 2017 Jan; 17(1):2. PubMed ID: 28061842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.